z-logo
open-access-imgOpen Access
P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA ‐ SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
Author(s) -
Pfeiffer C.,
Beer P.,
Asnagli H.,
Bolomsky A.,
Grandits A.,
Schneller A.,
Huber J.,
Zojer N.,
Schreder M.,
Parker A.,
Ludwig H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846336.64675.44
Subject(s) - propidium iodide , cell growth , cell culture , cell cycle , biology , cell cycle checkpoint , cancer research , annexin , apoptosis , growth inhibition , chemistry , microbiology and biotechnology , biochemistry , programmed cell death , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here